Eron JJ, Cook PP, Mehrotra ML, Huang H, et al. Lenacapavir Plus Two Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or Zinlirvimab. J Infect Dis 2025 Apr 3:jiaf159. doi: 10.1093.
PMID: 40176256